Financial PerformanceThe company's net loss forecast has been widened significantly due to harsh price cuts from bulk purchases, affecting profitability.
Market RisksThere are potential restrictions on bidding in EU public hospital tenders, putting a significant portion of the group's sales at risk.
Research And DevelopmentSignificant cuts in R&D expenses are expected, delaying the progress of new products and reducing future sales growth potential.